|
|
|
Volumn 106, Issue 12 Suppl, 1999, Pages 1-9
|
|
The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CARBONATE DEHYDRATASE INHIBITOR;
DORZOLAMIDE;
SULFONAMIDE;
THIOPHENE DERIVATIVE;
TIMOLOL;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG ADMINISTRATION;
DRUG COMBINATION;
DRUG EFFECT;
FEMALE;
HUMAN;
INTRAOCULAR HYPERTENSION;
INTRAOCULAR PRESSURE;
MALE;
MIDDLE AGED;
MULTICENTER STUDY;
OPEN ANGLE GLAUCOMA;
RANDOMIZED CONTROLLED TRIAL;
SAFETY;
VISUAL ACUITY;
VISUAL FIELD;
ADRENERGIC BETA-ANTAGONISTS;
ADULT;
AGED;
AGED, 80 AND OVER;
CARBONIC ANHYDRASE INHIBITORS;
DOUBLE-BLIND METHOD;
DRUG ADMINISTRATION SCHEDULE;
DRUG THERAPY, COMBINATION;
FEMALE;
GLAUCOMA, OPEN-ANGLE;
HUMANS;
INTRAOCULAR PRESSURE;
MALE;
MIDDLE AGED;
OCULAR HYPERTENSION;
SAFETY;
SULFONAMIDES;
THIOPHENES;
TIMOLOL;
VISUAL ACUITY;
VISUAL FIELDS;
|
|
EID: 0033447351
PISSN: 01616420
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (11)
|
|
References (0)
|
